172 related articles for article (PubMed ID: 23793103)
1. Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells.
Sung KW; Hahn SJ
Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct; 386(10):905-16. PubMed ID: 23793103
[TBL] [Abstract][Full Text] [Related]
2. Block of cloned Kv4.3 potassium channels by dapoxetine.
Jeong I; Kim SW; Yoon SH; Hahn SJ
Neuropharmacology; 2012 Jun; 62(7):2261-6. PubMed ID: 22192593
[TBL] [Abstract][Full Text] [Related]
3. Effects of haloperidol on Kv4.3 potassium channels.
Lee HJ; Sung KW; Hahn SJ
Eur J Pharmacol; 2014 Oct; 740():1-8. PubMed ID: 24998874
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene inhibits cloned Kv4.3 channels in an estrogen receptor-independent manner.
Chae YJ; Kim DH; Lee HJ; Sung KW; Kwon OJ; Hahn SJ
Pflugers Arch; 2015 Aug; 467(8):1663-76. PubMed ID: 25231973
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine blocks cloned Kv4.3 potassium channels.
Choi JS; Hahn SJ
Brain Res; 2012 Jul; 1466():15-23. PubMed ID: 22618310
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Kv4.3 potassium channels by trazodone.
Chae YJ; Choi JS; Hahn SJ
Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):711-9. PubMed ID: 23615873
[TBL] [Abstract][Full Text] [Related]
7. Interaction of riluzole with the closed inactivated state of Kv4.3 channels.
Ahn HS; Kim SE; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
J Pharmacol Exp Ther; 2006 Oct; 319(1):323-31. PubMed ID: 16815868
[TBL] [Abstract][Full Text] [Related]
8. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation.
Jeong I; Choi BH; Hahn SJ
Br J Pharmacol; 2011 Jun; 163(3):510-20. PubMed ID: 21232039
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.
Kim HJ; Ahn HS; Choi BH; Hahn SJ
Am J Physiol Cell Physiol; 2011 Mar; 300(3):C567-75. PubMed ID: 21148405
[TBL] [Abstract][Full Text] [Related]
11. Block of Kv4.3 potassium channel by trifluoperazine independent of CaMKII.
Chae YJ; Choi BH; Choi JS; Hahn SJ
Neurosci Lett; 2014 Aug; 578():159-64. PubMed ID: 24993295
[TBL] [Abstract][Full Text] [Related]
12. Effects of ranolazine on cloned cardiac kv4.3 potassium channels.
Kim HJ; Ahn HS; Choi JS; Choi BH; Hahn SJ
J Pharmacol Exp Ther; 2011 Dec; 339(3):952-8. PubMed ID: 21940646
[TBL] [Abstract][Full Text] [Related]
13. Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.
Jeong I; Choi BH; Hahn SJ
Pflugers Arch; 2010 Oct; 460(5):851-62. PubMed ID: 20734202
[TBL] [Abstract][Full Text] [Related]
14. Riluzole inhibits Kv4.2 channels acting on the closed and closed inactivated states.
Pacheco-Rojas DO; Delgado-Ramírez M; Villatoro-Gómez K; Moreno-Galindo EG; Rodríguez-Menchaca AA; Sánchez-Chapula JA; Ferrer T
Eur J Pharmacol; 2021 May; 899():174026. PubMed ID: 33722592
[TBL] [Abstract][Full Text] [Related]
15. Effects of fluoxetine on cloned Kv4.3 potassium channels.
Jeong I; Choi JS; Hahn SJ
Brain Res; 2013 Mar; 1500():10-8. PubMed ID: 23348380
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin-independent inhibition of KV1.3 by FK-506 (tacrolimus): a novel pharmacological property.
Ahn HS; Kim SE; Choi BH; Choi JS; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Kwon OJ; Hahn SJ
Am J Physiol Cell Physiol; 2007 May; 292(5):C1714-22. PubMed ID: 17166943
[TBL] [Abstract][Full Text] [Related]
17. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
[TBL] [Abstract][Full Text] [Related]
18. Effects of MiRP1 and DPP6 beta-subunits on the blockade induced by flecainide of Kv4.3/KChIP2 channels.
Radicke S; Vaquero M; Caballero R; Gómez R; Núñez L; Tamargo J; Ravens U; Wettwer E; Delpón E
Br J Pharmacol; 2008 Jun; 154(4):774-86. PubMed ID: 18536731
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action.
Fischer F; Vonderlin N; Zitron E; Seyler C; Scherer D; Becker R; Katus HA; Scholz EP
Naunyn Schmiedebergs Arch Pharmacol; 2013 Nov; 386(11):991-9. PubMed ID: 23832378
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K(+) channel.
Potet F; Bouyssou T; Escande D; Baró I
J Pharmacol Exp Ther; 2001 Dec; 299(3):1007-12. PubMed ID: 11714889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
